The phenotypic impact of the small molecule NNMT inhibitors on cancer cells was established by assessing the viability of OS and MCC cell lines by means of the MTT assay at different timepoints (0 h, 24 h, 48 h and 72 h) following treatment with the NNMT inhibitors. The gene discussed is NNMT; the disease is Merkel cell skin cancer.